In July of the same year, Holmes was introduced to former secretary of state, 

George
Shultz. After a two-hour meeting, Shultz joined the Theranos board of directors. 
Holmes was recognized for forming "the most illustrious board in U.S. corporate history"
over the next three (3) years. This includes:
a. William Perry, former U.S. Secretary of Defense, 
b. Henry Kissinger, former U.S. Secretary of State, 
c. Sam Nunn, former U.S. Senator, 
d. Bill Frist, former U.S. Senator, senate majority leader and heart-transplant
surgeon,
e. Gary Roughead, (Admiral, USN, retired), 
f. James Mattis (General, USMC), 
g. Richard Kovacevich, former Wells Fargo Chairman and CEO and 
h. Riley Bechtel, chairman of the board and former CEO at Bechtel Group.

Theranos worked in a "stealth mode" during its first years to focus on research and
fundraising without any press appearances or even a company website until September
2013. It is when the company announced a partnership with Walgreens, a global leader
in retail and wholesale pharmacy, to launch in-store blood sample collection centers at
more than 40 locations. This deal helped commercialized Theranos’ tests and opened
them to the public to reach consumers directly. She was then interviewed
for Medscape by its editor-in-chief, Eric Topol, who praised her for "this phenomenal
rebooting of laboratory medicine”. 
In 2014, Media attention increased when Holmes appeared on the covers
of Fortune, Forbes, T: The New York Times Style Magazine, and Inc. Forbes wherein
Holmes was recognized as the world's youngest self-made female billionaire and
ranked her #110 on the Forbes 400 in 2014. Theranos was valued at $9 billion and had
raised more than $400 million in venture capital. By the end of 2014, her name
appeared on 18 U.S. patents and 66 foreign patents.
In 2015, Holmes established agreements with Cleveland Clinic, Capital BlueCross
(central Pennsylvania’s largest health insurer with over 700,000 consumers), and
AmeriHealth Caritas to use Theranos technology.
In March 2015, the Cleveland Clinic announced a partnership with Theranos in order to
test its technology and lessen the cost of lab tests. Also in the same month, Holmes
became the youngest person ever honored as a lifetime member by the Horatio Alger
Association of Distinguished Americans.
In July 2015, Theranos became the lab-work provider for Pennsylvania insurers
AmeriHealth Caritas and Capital BlueCross. Theranos was valued at $10 billion.
Of the same month, the Food and Drug Administration (FDA) approved the use of the
company's fingerstick blood testing device for the herpes simplex virus 1 (HSV-1)
outside a clinical laboratory setting. Theranos was awarded the 2015 Bioscience
Company of the Year by the Arizona BioIndustry Association (AzBio).
Also, on July 2015, Joe Biden visited Theranos facility and said “Talk about
inspirational, this is inspirational”
On the same year, Forbes had named Holmes the youngest and wealthiest self-made
female billionaire in America on the basis of a $9-billion valuation of her company.
In April 2016, Theranos announced its medical advisory board which included past
presidents or board members of the American Association for Clinical Chemistry which
includes:
a. Susan A. Evans, 
b. William Foege, former director U.S. Centers for Disease Control and
Prevention (CDC),
c. David Helfet, director of the Orthopedic Trauma Service at the Hospital for
Special Surgery
d. Ann M. Gronowski,
e. Larry J. Kricka,
f. Jack Ladenson,
g. Andy O. Miller and
h. Steven Spitalnik.
In August 2016, Theranos introduced a new robotic, capillary blood testing unit named
"miniLab" at the 2016 annual meeting of the American Association for Clinical
Chemistry, a healthcare convention held in Philadelphia. The “minilab” was allegedly
capable of carrying out a range of tests with just a small amount of blood.
Unfortunately, on the same year, investigations against Theranos began and showed a
potential fraud about Theranos' claims, Forbes had revised its published estimate of
Holmes's net worth to zero, and Fortune had named her to be one of the "World's Most
Disappointing Leaders".
For a scientist, Holmes has a notable relationship with her faith, drawing on it when the
weeks in the lab are long and the criticism is loud. "My belief in God has played a huge
role in everything that I've done," says Holmes, who brings up God multiple times
throughout our discussion, although she won't specify her faith. "When you don't have
anybody to talk to and when you're going through something that's hard and believing
that you're doing that because there's something greater that's going to come from it--
that you can't even understand--that gives you the strength to keep going." the way
Holmes sees it, Theranos is her deeper calling.